Company Profile

Focused on your needs

A simple, unified Teva offers adaptive and accessible solutions for patients

We at Teva are committed to putting people at the center of what we do. By building on our strong global presence and harnessing our size and scale, we are increasing access to quality health solutions with the potential to help millions of people around the world. We do this by striving to develop and produce affordable, high-quality generic drugs, innovative specialty pharmaceuticals, and active pharmaceutical ingredients.

Teva Pharmaceuticals: We Are All In for Better Health

Family dramas; falling in love; health concerns. Around the world, we all share many of the same life experiences. But we don’t all have the same health needs. Every day, Teva Pharmaceuticals helps around 200 million people gain access to quality medicines. We are all in for better health – to ensure a healthier future for our planet and for people all around the world.

It is our employees who are at the core of our success as a global pharmaceutical leader and the world’s largest generic medicines producer. We have colleagues in over 60 countries that develop, produce, and deliver the “world’s largest medicine cabinet” to 200 million people every day 01.

By simplifying and unifying our business, we are working to meet the needs of our stakeholders and keep our promise to build a sustainable business. Our goal is to meet the current needs of patients and caregivers by continually developing our diverse portfolio of products and solutions, and we strive to anticipate future patient needs by evolving through research and development through key therapeutic areas, business development, and innovation. 

We wake up with pride every morning knowing that we help improve people's lives, while ensuring the highest standards of compliance and business integrity in everything we do.

Meet Teva’s Corporate Officers

 


Footnotes

  1. Back to contents.

    Internal analyses conducted by Global Insights, Access & Technologies estimating number of Teva consumers. Ref 2.1 dated August 2016; Ref 2.2 dated April 2019

Share this article: